Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKAG1 | P54619 | 1/20 | 0.39 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.39 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.37 |
| ▸ | PI4KA | P42356 | 1/20 | 0.37 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.37 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.37 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31170697 | 0.89 | PI4KA (0.39) | ADORA1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL27597373 | 0.89 | PI4KA (0.39) | ADORA1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL16112350 | 0.89 | PI4KA (0.47) | ADORA1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL31472972 | 0.84 | PI4KA (0.36) | ADORA1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL12541776 | 0.82 | PI4KA (0.38) | ADORA1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL28603431 | 0.81 | PI4KA (0.39) | ADORA1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL5218286 | 0.80 | ADORA2A (0.44) | ADORA1ADORA3ADORA2A | |
| SCHEMBL29974446 | 0.79 | PI4KA (0.40) | ADORA1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL41364 | 0.79 | PI4KA (0.43) | ADORA1PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL2228473 | 0.78 | PI4KA (0.39) | ADORA1PI4KAPI4K2BPI4K2API4KB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024019801-A1 | SYSTEMS AND METHODS FOR PROMOTING TRANS-SPLICING | TACIT THERAPEUTICS, INC. (US) | 2024-01-25 | — | — | WO | disclosed |
| EP-4125930-A1 | DUAL-ACTING SIRNA BASED MODULATION OF C9ORF72 | University Of Massachusetts (US) | 2023-02-08 | — | — | EP | disclosed |
| WO-2021195510-A1 | DUAL-ACTING SIRNA BASED MODULATION OF C9ORF72 | UNIVERSITY OF MASSACHUSETTS (US) | 2021-09-30 | — | — | WO | disclosed |
| CN-106434857-A | TD probe and its uses | SEEGENE株式会社 | 2017-02-22 | — | — | CN | disclosed |
| CN-106399484-A | Double bubble shape fluorescence probe, applications thereof, and kit | 中国人民解放军第三军医大学第附属医院 | 2017-02-15 | — | — | CN | disclosed |
| CN-102770556-B | Targeted probes and uses thereof | SEEGENE株式会社 | 2016-09-14 | — | — | CN | disclosed |
| EP-2046993-A2 | RNA SILENCING COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUNTINGTON'S DISEASE | University of Massachusetts (US) | 2009-04-15 | — | — | EP | disclosed |
| WO-2008005562-A2 | RNA SILENCING COMPOSITIONS AND METHODS FOR THE TREATMENT OF HUNTINGTON'S DISEASE | UNIVERSITY OF MASSACHUSETTS (US) | 2008-01-10 | — | — | WO | disclosed |